25.7 C
New York
Thursday, June 4, 2026

Tag: Regulatory

MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial

MAIA’s novel telomere-targeting therapy being evaluated as a third-line treatment for advanced non-small cell lung cancer

Greenland Mines Completes Site Visit to Sarfartoq Nd-Pr Rare Earth Magnet Project in Greenland; Prepares 2026 Field Program

CHARLOTTE, N.C., June 4, 2026 /PRNewswire/ -- Greenland Mines Ltd ("Greenland Mines" or the "Company") (Nasdaq: GRML) today announced that its Greenland operations team has...

LanzaTech JV Successful IPO Underscores Strategic Value of More Secure Fuel Supply

SKOKIE, Ill., June 04, 2026 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (NASDAQ: LNZA) (“LanzaTech” or the “Company”), a carbon management solutions company, announced that Beijing Shougang LanzaTech Technology Co., Ltd., (the “JV”), a joint venture in which LanzaTech held a 9.31% equity stake prior to the offering described below, has launched its Initial Public Offering (IPO) of 40 million H-Shares at a public offering price equivalent to approximately US$1.86 per share, based on applicable exchange rates, on the Hong Kong Stock Exchange. The offering raised gross proceeds of approximately US$75M before underwriting discounts and commissions.

Univar Solutions Expands Partnership with BASF Petrochemicals as Exclusive Distributor of Hexamoll® DINCH Across North America

DOWNERS GROVE, Ill., June 4, 2026 /CNW/ -- Univar Solutions, LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of...

Univar Solutions Expands Partnership with BASF Petrochemicals as Exclusive Distributor of Hexamoll® DINCH Across North America

DOWNERS GROVE, Ill., June 4, 2026 /PRNewswire/ -- Univar Solutions, LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of...

Univar Solutions Expands Partnership with BASF Petrochemicals as Exclusive Distributor of Hexamoll® DINCH Across North America

DOWNERS GROVE, Ill., June 4, 2026 /PRNewswire/ -- Univar Solutions, LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of...

Global-e Announces Board Authorization of $500 Million Share Repurchase Program

PETAH-TIKVA, Israel, June 04, 2026 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE), the platform powering global direct-to-consumer e-commerce, today announced that its Board of Directors (the "Board") has approved a “distribution”, as defined in the Israeli Companies Law, 5759-1999 (the “Companies Law”) by way of a share repurchase program, pursuant to which the Company may repurchase an aggregate amount of up to $500 million of its ordinary shares (the “Distribution”), subject to the completion of required Israeli regulatory procedures.

LIGHT AI ANNOUNCES INITIATION OF FDA PIVOTAL CLINICAL TRIAL FOR QUICKSCAN™ STREP A SOFTWARE AS A MEDICAL DEVICE (SaMD)

Ethics Committee Approval Received for Pivotal Study Intended to Support U.S. FDA Class II Submission for QuickScan™ Strep AVANCOUVER, BC, June 4, 2026 /CNW/...

HotSpot Therapeutics Presents Preclinical Data from Small Molecule IRF5 Inhibitor Program at EULAR 2026

BOSTON, June 4, 2026 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of oral, allosteric small molecules that target...

X-energy Reports First Quarter 2026 Results

X-energy Reports First Quarter 2026 Results

ACE Money Transfer Limited Partners with Philippine National Bank to Simplify Remittances for Filipino Expats

Manila, Philippines, June 04, 2026 (GLOBE NEWSWIRE) -- ACE Money Transfer Limited, a leading remittance company, regulated and authorized by the Financial Conduct Authority UK and operating in UK, Europe, Australia, and Canada, through its regulated entities, has announced a strategic partnership with Philippine National Bank (PNB), one of the Philippines’ top financial institutions, to enhance money transfer services for Filipino expats worldwide.

World’s First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory...

SAN FRANCISCO and SUZHOU, China, June 4, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...

Share Buyback Transaction Details May 28 – June 3, 2026

PRESS RELEASE                                        

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRegulatory